SLC16A9
Monocarboxylate transporter 9
Also known as: C10orf36, FLJ43803, MCT9, MOT9_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q7RTY1
- Gene
- SLC16A9
- Ensembl
- ENSG00000165449
- Chromosome
- 10
- Canonical length
- 509 aa
- Protein class
- Metabolic proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Nucleoplasm,Cell Junctions
OverviewNCBI Gene
Enables carnitine transmembrane transporter activity and creatine transmembrane transporter activity. Involved in carnitine transmembrane transport; creatine transmembrane transport; and urate metabolic process. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
509 residues, UniProt reviewed canonical sequence.
>Q7RTY1|SLC16A9
1 MELKKSPDGG WGWVIVFVSF LTQFLCYGSP LAVGVLYIEW LDAFGEGKGK TAWVGSLASG
61 VGLLASPVCS LCVSSFGARP VTIFSGFMVA GGLMLSSFAP NIYFLFFSYG IVVGLGCGLL
121 YTATVTITCQ YFDDRRGLAL GLISTGSSVG LFIYAALQRM LVEFYGLDGC LLIVGALALN
181 ILACGSLMRP LQSSDCPLPK KIAPEDLPDK YSIYNEKGKN LEENINILDK SYSSEEKCRI
241 TLANGDWKQD SLLHKNPTVT HTKEPETYKK KVAEQTYFCK QLAKRKWQLY KNYCGETVAL
301 FKNKVFSALF IAILLFDIGG FPPSLLMEDV ARSSNVKEEE FIMPLISIIG IMTAVGKLLL
361 GILADFKWIN TLYLYVATLI IMGLALCAIP FAKSYVTLAL LSGILGFLTG NWSIFPYVTT
421 KTVGIEKLAH AYGILMFFAG LGNSLGPPIV GWFYDWTQTY DIAFYFSGFC VLLGGFILLL
481 AALPSWDTCN KQLPKPAPTT FLYKVASNVLocalizationUniProt · AlphaFold · HPA
Whether an antibody against SLC16A9 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 12
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 178 nTPM
Expression across tissuesHPA
Tissue
- kidney: 178 nTPM
- adrenal gland: 143 nTPM
- ovary: 41 nTPM
- spleen: 38 nTPM
- parathyroid gland: 27 nTPM
- fallopian tube: 21 nTPM
Single-cell type
- proximal tubule cells: 1,103 nCPM
- adrenal cortex cells: 850 nCPM
- choroid plexus epithelial cells: 201 nCPM
- astrocytes: 143 nCPM
- esophageal apical cells: 119 nCPM
- colonocytes: 100 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- choroid plexus: 26 nTPM
- hypothalamus: 23 nTPM
- white matter: 19 nTPM
- medulla oblongata: 17 nTPM
- midbrain: 17 nTPM
- spinal cord: 16 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0.01
- gnomAD missense Z
- 0.7
- DepMap mean gene effect
- 0.05
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carboxylic acid transmembrane transport
- carnitine transmembrane transport
- creatine transmembrane transport
- urate metabolic process
Molecular functions
- carnitine transmembrane transporter activity
- creatine transmembrane transporter activity
- monocarboxylic acid transmembrane transporter activity
- symporter activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads SLC16A9 as an antibody target. Whether an autoantibody or antibody against SLC16A9 could matter depends on whether native SLC16A9 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
SLC16A9 is annotated at the cell surface, where native SLC16A9 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label SLC16A9 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...